1. Home
  2. WLY vs RDY Comparison

WLY vs RDY Comparison

Compare WLY & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WLY
  • RDY
  • Stock Information
  • Founded
  • WLY 1807
  • RDY 1984
  • Country
  • WLY United States
  • RDY India
  • Employees
  • WLY N/A
  • RDY N/A
  • Industry
  • WLY Books
  • RDY Biotechnology: Pharmaceutical Preparations
  • Sector
  • WLY Consumer Discretionary
  • RDY Health Care
  • Exchange
  • WLY Nasdaq
  • RDY Nasdaq
  • Market Cap
  • WLY 2.3B
  • RDY 2.1B
  • IPO Year
  • WLY N/A
  • RDY N/A
  • Fundamental
  • Price
  • WLY $38.79
  • RDY $14.63
  • Analyst Decision
  • WLY
  • RDY Buy
  • Analyst Count
  • WLY 0
  • RDY 1
  • Target Price
  • WLY N/A
  • RDY $17.00
  • AVG Volume (30 Days)
  • WLY 448.9K
  • RDY 1.6M
  • Earning Date
  • WLY 06-17-2025
  • RDY 05-09-2025
  • Dividend Yield
  • WLY 3.60%
  • RDY 0.65%
  • EPS Growth
  • WLY N/A
  • RDY 1.46
  • EPS
  • WLY 0.75
  • RDY 0.79
  • Revenue
  • WLY $1,703,491,000.00
  • RDY $3,809,801,863.00
  • Revenue This Year
  • WLY N/A
  • RDY $10.24
  • Revenue Next Year
  • WLY $1.13
  • RDY N/A
  • P/E Ratio
  • WLY $52.13
  • RDY $18.43
  • Revenue Growth
  • WLY N/A
  • RDY 16.61
  • 52 Week Low
  • WLY $34.85
  • RDY $12.26
  • 52 Week High
  • WLY $53.96
  • RDY $16.89
  • Technical
  • Relative Strength Index (RSI)
  • WLY 26.04
  • RDY 63.81
  • Support Level
  • WLY $40.25
  • RDY $14.24
  • Resistance Level
  • WLY $41.12
  • RDY $14.77
  • Average True Range (ATR)
  • WLY 0.97
  • RDY 0.20
  • MACD
  • WLY -0.49
  • RDY 0.04
  • Stochastic Oscillator
  • WLY 7.78
  • RDY 95.59

About WLY John Wiley & Sons Inc.

John Wiley & Sons Inc is one of the world's greatest publishers and a trusted leader in research and learning. Its industry-principal content, services, platforms, and knowledge networks are tailored to meet the evolving needs of its customers and partners, including researchers, students, instructors, professionals, institutions, and corporations. The company empowers knowledge-seekers to transform today's obstacles into tomorrow's brightest opportunities. For more than two centuries, the company has been delivering on its timeless mission to unlock human potential.

About RDY Dr. Reddy's Laboratories Ltd

Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.

Share on Social Networks: